Our team

Ken Cheng

Metagone Biotech Group Founder

  • Dongguan Shun Cheng Computer Enteprise Corporation Director of Board
  • Solytech Enteprise Corporation President
  • Experiences in R&D and manufacturing departments of electronic components industry management for over 30 years
  • Biotech investing over 10 years experience

Sean Chen Ph.D.

President/General Manager

  • MS/Ph.D., Neuroscience, College of Medicine, Ohio State University, Columbus, USA
  • Research Fellow, Whitehead Institute for Biomedical Research, MIT, Boston, USA
  • Department Head, R&D, Genovate Biotechnology Co., Ltd. Taiwan
  • Founder/Board Director/General Manager, Transwell Biotechnology Co., Ltd. Taiwan
  • Experiences in Drug development for over 30 years

Da-Wen Lu, Professor, M.D., Ph.D.

Medical Director

  • Director, General Ophthalmology Department, Tri-Service General Hospital
  • Director, Department of Glaucoma, Tri-Service General Hospital
  • Professor, Department of Ophthalmology, National Defense Medical Center
  • Chairman, Taiwan association for relief of glaucoma and effective therapy

Cheng-Kuo, Cheng, Associate Professor, M.D.

Medical Director

  • Director, Department of ophthalmology and Retina Center of Shin Kong Hospital
  • Executive Director, Taiwan Retina Society
  • Associate Professor, Department of Medicine, Fu Jen Catholic University
  • Director, Department of Ophthalmology, Fu Jen Catholic University
  • Adjunct Assistant Professor, Department of Medicine, National Taiwan University

Cheng-Wen Lin Ph.D.

Chief Scientific Officer

  • Ph.D., Biomedical Engineering, Durham, NC, Duke University
  • Postdoctoral Fellow, Durham, NC, Duke University Eye Center
  • Director of Research (Executive level), Aerie Pharmaceuticals, Inc. (now Alcon)
  • Chief Scientific Officer, Perfuse Therapeutics, Inc.
  • Experiences in ocular drug research and development for over 15 years
  • Discovered and developed two marketed products (Rhopressa® & Rocklatan®)

Akaphot Thongmee (Mark), M.D.

Chief Medical Officer

  • Master., Research in Clinical Research, Imperial College London, UK
  • Global Head, Medical Affairs, Grand Pacific Contract Research Organization (GPCRO)
  • Medical Affairs Head (TH&VN) at Allergan Ltd.
  • Country Medical Lead at Amgen (Thailand) Ltd.
  • Medical advisor, Department of Oncology, Novartis International AG.
  • Medical advisor/Product physician, Innovative oncology portfolio, Pfizer (Thai) Ltd.
  • More than 20 years of medical advisor experience at multinational pharmaceutical companies

Simon Huang

Executive Vice President

  • NYIT M.B.A.
  • Barits Securities Corporation Researcher
  • Solytech Enteprise Corporation Independent President
  • Taipei Biotech Association Supervisor
  • Professional experiences in clinical trail over 6 years
  • Professional experiences (including the experiences of the securities industry and the investment company) in financial industry and capital market for over 20 years.

Amy Chen

Chief Financial Officer & Office of General Affairs, Director

  • Royal Roads University M.B.A. in Executive Management
  • Wayi International Digital Entertainment Co.,Ltd. Manager
  • Professional experiences in financial management and fund allocation for over 25 years.

Te Chung Yang

Product Evaluation and Market Research, Director

  • National Defense Medical Center Master of Pharmacy Institute
  • Tri-Service General Hospital, Department of Clinical Pharmacy, Chief Pharmacist
  • Tri-Service General Hospital, Department of Clinical Pharmacy, Quality Control and Clinical Trial Pharmacist
  • Tri-Service General Hospital, Department of Clinical Pharmacy, Head of Neihu Outpatient Pharmacy Bureau
  • Experiences in Clinical Pharmacy over 30 years